HEADER HYDROLASE, VIRAL PROTEIN 04-MAR-19 6O5X TITLE CRYSTAL STRUCTURE OF MULTI-DRUG RESISTANT HIV-1 PROTEASE PR-S17 WITH TITLE 2 SUBSTRATE ANALOG CA-P2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE PR-S17; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HIV PROTEASE, HYDROLASE, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.AGNISWAMY,Y.-F.WANG,I.T.WEBER REVDAT 4 11-OCT-23 6O5X 1 LINK REVDAT 3 18-DEC-19 6O5X 1 REMARK REVDAT 2 17-JUL-19 6O5X 1 REMARK REVDAT 1 19-JUN-19 6O5X 0 JRNL AUTH J.AGNISWAMY,D.W.KNELLER,R.BROTHERS,Y.F.WANG,R.W.HARRISON, JRNL AUTH 2 I.T.WEBER JRNL TITL HIGHLY DRUG-RESISTANT HIV-1 PROTEASE MUTANT PRS17 SHOWS JRNL TITL 2 ENHANCED BINDING TO SUBSTRATE ANALOGUES. JRNL REF ACS OMEGA V. 4 8707 2019 JRNL REFN ESSN 2470-1343 JRNL PMID 31172041 JRNL DOI 10.1021/ACSOMEGA.9B00683 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0123 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 44127 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2291 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3081 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.1860 REMARK 3 BIN FREE R VALUE SET COUNT : 149 REMARK 3 BIN FREE R VALUE : 0.2300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3044 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 131 REMARK 3 SOLVENT ATOMS : 170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.38000 REMARK 3 B22 (A**2) : -0.13000 REMARK 3 B33 (A**2) : 0.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.58000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.102 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.102 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3296 ; 0.024 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3408 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4491 ; 2.218 ; 2.021 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7818 ; 3.595 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 409 ; 7.099 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 117 ;42.299 ;24.530 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 556 ;12.091 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;10.947 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 540 ; 0.141 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3685 ; 0.013 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 717 ; 0.020 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1630 ; 2.133 ; 1.789 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1630 ; 2.132 ; 1.789 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2038 ; 3.018 ; 2.671 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2039 ; 3.017 ; 2.671 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1666 ; 3.609 ; 2.239 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1667 ; 3.608 ; 2.239 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2453 ; 5.401 ; 3.185 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3276 ; 6.447 ;14.955 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3235 ; 6.449 ;14.847 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6O5X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1000240078. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46434 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.41800 REMARK 200 R SYM FOR SHELL (I) : 0.41800 REMARK 200 FOR SHELL : 6.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5T2Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.1M SODIUM CHLORIDE, 0.1M HEPES PH REMARK 280 7.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.17900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -75.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -84.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 34 CD GLU B 34 OE1 0.078 REMARK 500 GLN D 7 CD GLN D 7 OE1 0.135 REMARK 500 SER D 82 CB SER D 82 OG 0.101 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 29 CB - CG - OD1 ANGL. DEV. = 6.1 DEGREES REMARK 500 ARG B 20 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ASP B 29 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 ARG B 87 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ASP D 29 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG D 87 NE - CZ - NH1 ANGL. DEV. = 4.9 DEGREES REMARK 500 ARG D 87 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 35 42.70 -103.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 104 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN B 61 O REMARK 620 2 HOH B 209 O 88.2 REMARK 620 3 PHE C 99 O 98.4 66.1 REMARK 620 4 LEU D 93 O 96.7 66.7 1.8 REMARK 620 5 HOH D 231 O 102.4 88.3 146.4 147.9 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L- REMARK 630 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA-GLUTAMYL-L- REMARK 630 ALANYL-L-NORLEUCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0Q4 B 101 REMARK 630 0Q4 D 101 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ARG VAL DC0 GLU ALA NLE NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0Q4 B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA B 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0Q4 D 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL D 102 DBREF 6O5X A 1 99 UNP I7BFC3 I7BFC3_9HIV1 1 99 DBREF 6O5X B 1 99 UNP I7BFC3 I7BFC3_9HIV1 1 99 DBREF 6O5X C 1 99 UNP I7BFC3 I7BFC3_9HIV1 1 99 DBREF 6O5X D 1 99 UNP I7BFC3 I7BFC3_9HIV1 1 99 SEQADV 6O5X LEU A 46 UNP I7BFC3 MET 46 ENGINEERED MUTATION SEQADV 6O5X VAL A 48 UNP I7BFC3 GLY 48 ENGINEERED MUTATION SEQADV 6O5X ALA A 67 UNP I7BFC3 CYS 67 ENGINEERED MUTATION SEQADV 6O5X ILE A 77 UNP I7BFC3 VAL 77 ENGINEERED MUTATION SEQADV 6O5X SER A 82 UNP I7BFC3 ALA 82 ENGINEERED MUTATION SEQADV 6O5X LEU A 93 UNP I7BFC3 ILE 93 ENGINEERED MUTATION SEQADV 6O5X ALA A 95 UNP I7BFC3 CYS 95 ENGINEERED MUTATION SEQADV 6O5X LEU B 46 UNP I7BFC3 MET 46 ENGINEERED MUTATION SEQADV 6O5X VAL B 48 UNP I7BFC3 GLY 48 ENGINEERED MUTATION SEQADV 6O5X ALA B 67 UNP I7BFC3 CYS 67 ENGINEERED MUTATION SEQADV 6O5X ILE B 77 UNP I7BFC3 VAL 77 ENGINEERED MUTATION SEQADV 6O5X SER B 82 UNP I7BFC3 ALA 82 ENGINEERED MUTATION SEQADV 6O5X LEU B 93 UNP I7BFC3 ILE 93 ENGINEERED MUTATION SEQADV 6O5X ALA B 95 UNP I7BFC3 CYS 95 ENGINEERED MUTATION SEQADV 6O5X LEU C 46 UNP I7BFC3 MET 46 ENGINEERED MUTATION SEQADV 6O5X VAL C 48 UNP I7BFC3 GLY 48 ENGINEERED MUTATION SEQADV 6O5X ALA C 67 UNP I7BFC3 CYS 67 ENGINEERED MUTATION SEQADV 6O5X ILE C 77 UNP I7BFC3 VAL 77 ENGINEERED MUTATION SEQADV 6O5X SER C 82 UNP I7BFC3 ALA 82 ENGINEERED MUTATION SEQADV 6O5X LEU C 93 UNP I7BFC3 ILE 93 ENGINEERED MUTATION SEQADV 6O5X ALA C 95 UNP I7BFC3 CYS 95 ENGINEERED MUTATION SEQADV 6O5X LEU D 46 UNP I7BFC3 MET 46 ENGINEERED MUTATION SEQADV 6O5X VAL D 48 UNP I7BFC3 GLY 48 ENGINEERED MUTATION SEQADV 6O5X ALA D 67 UNP I7BFC3 CYS 67 ENGINEERED MUTATION SEQADV 6O5X ILE D 77 UNP I7BFC3 VAL 77 ENGINEERED MUTATION SEQADV 6O5X SER D 82 UNP I7BFC3 ALA 82 ENGINEERED MUTATION SEQADV 6O5X LEU D 93 UNP I7BFC3 ILE 93 ENGINEERED MUTATION SEQADV 6O5X ALA D 95 UNP I7BFC3 CYS 95 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU ARG GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU ASP ILE ASP LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS LEU ILE VAL GLY ILE GLY GLY SEQRES 5 A 99 PHE VAL LYS VAL ARG GLN TYR GLU GLN VAL PRO ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS VAL VAL GLY THR VAL LEU ILE GLY SEQRES 7 A 99 PRO THR PRO SER ASN ILE ILE GLY ARG ASN LEU MET THR SEQRES 8 A 99 GLN LEU GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU ARG GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU ASP ILE ASP LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS LEU ILE VAL GLY ILE GLY GLY SEQRES 5 B 99 PHE VAL LYS VAL ARG GLN TYR GLU GLN VAL PRO ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS VAL VAL GLY THR VAL LEU ILE GLY SEQRES 7 B 99 PRO THR PRO SER ASN ILE ILE GLY ARG ASN LEU MET THR SEQRES 8 B 99 GLN LEU GLY ALA THR LEU ASN PHE SEQRES 1 C 99 PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE SEQRES 2 C 99 LYS ILE GLY GLY GLN LEU ARG GLU ALA LEU LEU ASP THR SEQRES 3 C 99 GLY ALA ASP ASP THR VAL LEU GLU ASP ILE ASP LEU PRO SEQRES 4 C 99 GLY ARG TRP LYS PRO LYS LEU ILE VAL GLY ILE GLY GLY SEQRES 5 C 99 PHE VAL LYS VAL ARG GLN TYR GLU GLN VAL PRO ILE GLU SEQRES 6 C 99 ILE ALA GLY HIS LYS VAL VAL GLY THR VAL LEU ILE GLY SEQRES 7 C 99 PRO THR PRO SER ASN ILE ILE GLY ARG ASN LEU MET THR SEQRES 8 C 99 GLN LEU GLY ALA THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU ARG GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL LEU GLU ASP ILE ASP LEU PRO SEQRES 4 D 99 GLY ARG TRP LYS PRO LYS LEU ILE VAL GLY ILE GLY GLY SEQRES 5 D 99 PHE VAL LYS VAL ARG GLN TYR GLU GLN VAL PRO ILE GLU SEQRES 6 D 99 ILE ALA GLY HIS LYS VAL VAL GLY THR VAL LEU ILE GLY SEQRES 7 D 99 PRO THR PRO SER ASN ILE ILE GLY ARG ASN LEU MET THR SEQRES 8 D 99 GLN LEU GLY ALA THR LEU ASN PHE HET CL A 101 1 HET CL A 102 1 HET CL A 103 1 HET CL A 104 1 HET 0Q4 B 101 59 HET CL B 102 1 HET CL B 103 1 HET NA B 104 1 HET CL C 101 1 HET CL C 102 1 HET CL C 103 1 HET CL C 104 1 HET CL C 105 1 HET 0Q4 D 101 66 HET CL D 102 1 HETNAM CL CHLORIDE ION HETNAM 0Q4 N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L- HETNAM 2 0Q4 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA- HETNAM 3 0Q4 GLUTAMYL-L-ALANYL-L-NORLEUCINAMIDE HETNAM NA SODIUM ION HETSYN 0Q4 INHIBITOR ANALOGUES OF CA-P2 FORMUL 5 CL 12(CL 1-) FORMUL 9 0Q4 2(C40 H70 N11 O8 1+) FORMUL 12 NA NA 1+ FORMUL 20 HOH *170(H2 O) HELIX 1 AA1 GLY A 86 THR A 91 1 6 HELIX 2 AA2 GLN A 92 GLY A 94 5 3 HELIX 3 AA3 GLY B 86 THR B 91 1 6 HELIX 4 AA4 GLN B 92 GLY B 94 5 3 HELIX 5 AA5 GLY C 86 GLY C 94 1 9 HELIX 6 AA6 GLY D 86 THR D 91 1 6 HELIX 7 AA7 GLN D 92 GLY D 94 5 3 SHEET 1 AA1 4 GLN A 2 THR A 4 0 SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 96 SHEET 4 AA1 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AA2 8 LYS A 43 GLY A 49 0 SHEET 2 AA2 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 AA2 8 HIS A 69 ILE A 77 -1 O VAL A 71 N ILE A 64 SHEET 4 AA2 8 VAL A 32 LEU A 33 1 N LEU A 33 O LEU A 76 SHEET 5 AA2 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA2 8 ILE A 10 ILE A 15 -1 N ILE A 13 O ARG A 20 SHEET 8 AA2 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 AA3 8 LYS B 43 GLY B 49 0 SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 AA3 8 HIS B 69 ILE B 77 -1 O VAL B 71 N ILE B 64 SHEET 4 AA3 8 VAL B 32 LEU B 33 1 N LEU B 33 O LEU B 76 SHEET 5 AA3 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 AA3 8 ILE B 10 ILE B 15 -1 N ILE B 15 O GLN B 18 SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 AA4 4 GLN C 2 ILE C 3 0 SHEET 2 AA4 4 THR D 96 ASN D 98 -1 O LEU D 97 N ILE C 3 SHEET 3 AA4 4 THR C 96 ASN C 98 -1 N ASN C 98 O THR D 96 SHEET 4 AA4 4 GLN D 2 THR D 4 -1 O ILE D 3 N LEU C 97 SHEET 1 AA5 8 LYS C 43 GLY C 49 0 SHEET 2 AA5 8 GLY C 52 ILE C 66 -1 O GLN C 58 N LYS C 43 SHEET 3 AA5 8 HIS C 69 ILE C 77 -1 O VAL C 75 N TYR C 59 SHEET 4 AA5 8 VAL C 32 LEU C 33 1 N LEU C 33 O LEU C 76 SHEET 5 AA5 8 ILE C 84 ILE C 85 -1 O ILE C 84 N VAL C 32 SHEET 6 AA5 8 GLN C 18 LEU C 24 1 N LEU C 23 O ILE C 85 SHEET 7 AA5 8 ILE C 10 ILE C 15 -1 N ILE C 15 O GLN C 18 SHEET 8 AA5 8 GLY C 52 ILE C 66 -1 O GLU C 65 N LYS C 14 SHEET 1 AA6 8 LYS D 43 GLY D 49 0 SHEET 2 AA6 8 GLY D 52 ILE D 66 -1 O GLN D 58 N LYS D 43 SHEET 3 AA6 8 HIS D 69 ILE D 77 -1 O HIS D 69 N ILE D 66 SHEET 4 AA6 8 VAL D 32 LEU D 33 1 N LEU D 33 O LEU D 76 SHEET 5 AA6 8 ILE D 84 ILE D 85 -1 O ILE D 84 N VAL D 32 SHEET 6 AA6 8 GLN D 18 LEU D 24 1 N LEU D 23 O ILE D 85 SHEET 7 AA6 8 ILE D 10 ILE D 15 -1 N VAL D 11 O ALA D 22 SHEET 8 AA6 8 GLY D 52 ILE D 66 -1 O GLU D 65 N LYS D 14 LINK O GLN B 61 NA NA B 104 1555 1555 2.18 LINK NA NA B 104 O HOH B 209 1555 1555 2.43 LINK NA NA B 104 O PHE C 99 2545 1555 2.35 LINK NA NA B 104 O LEU D 93 2545 1555 2.33 LINK NA NA B 104 O HOH D 231 1555 2555 2.40 SITE 1 AC1 2 ARG A 8 HOH B 239 SITE 1 AC2 2 GLY A 40 ARG A 41 SITE 1 AC3 2 VAL A 48 0Q4 B 101 SITE 1 AC4 2 THR A 12 ALA A 67 SITE 1 AC5 29 ARG A 8 LEU A 23 ASP A 25 GLY A 27 SITE 2 AC5 29 ALA A 28 ASP A 29 ASP A 30 VAL A 48 SITE 3 AC5 29 GLY A 49 CL A 103 ARG B 8 ASP B 25 SITE 4 AC5 29 GLY B 27 ALA B 28 ASP B 29 ASP B 30 SITE 5 AC5 29 LEU B 46 ILE B 47 VAL B 48 GLY B 49 SITE 6 AC5 29 ILE B 50 SER B 82 HOH B 203 HOH B 205 SITE 7 AC5 29 HOH B 230 HOH B 235 LYS D 45 LEU D 46 SITE 8 AC5 29 0Q4 D 101 SITE 1 AC6 3 GLY B 73 THR B 74 ASN B 88 SITE 1 AC7 2 VAL B 54 LYS B 55 SITE 1 AC8 2 GLN B 61 HOH B 209 SITE 1 AC9 3 THR C 4 TRP C 6 GLN C 7 SITE 1 AD1 2 LEU B 46 ARG C 8 SITE 1 AD2 3 ILE C 47 VAL C 48 0Q4 D 101 SITE 1 AD3 2 ARG C 8 HOH D 232 SITE 1 AD4 1 THR C 12 SITE 1 AD5 33 LYS B 45 LEU B 46 0Q4 B 101 ARG C 8 SITE 2 AD5 33 LEU C 23 ASP C 25 GLY C 27 ALA C 28 SITE 3 AD5 33 ASP C 29 VAL C 48 GLY C 49 CL C 103 SITE 4 AD5 33 HOH C 220 ARG D 8 LEU D 23 ASP D 25 SITE 5 AD5 33 GLY D 27 ALA D 28 ASP D 29 ASP D 30 SITE 6 AD5 33 LEU D 46 ILE D 47 VAL D 48 GLY D 49 SITE 7 AD5 33 ILE D 50 PRO D 81 SER D 82 HOH D 201 SITE 8 AD5 33 HOH D 202 HOH D 203 HOH D 204 HOH D 207 SITE 9 AD5 33 HOH D 210 SITE 1 AD6 2 THR D 74 ASN D 88 CRYST1 53.704 60.358 66.476 90.00 90.93 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018621 0.000000 0.000303 0.00000 SCALE2 0.000000 0.016568 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015045 0.00000